Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly Exchange Rate Effect of -$138000.0 in Q1 2026, down 220.93% quarter-over-quarter from -$43000.0 in Q4 2025, and down 159.48% on a YoY basis from $232000.0 in Q1 2025.
Ionis Pharmaceuticals (IONS) Exchange Rate Effect (2019 - 2026) Analysis & Trends
Ionis Pharmaceuticals' Exchange Rate Effect history runs 8 years deep, the most recent figure standing at -$138000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 159.48% year-over-year to -$138000.0; the TTM figure through Mar 2026 stood at $332000.0 (up 354.79% YoY), while the FY2025 annual figure was $702000.0, up 357.14% from the prior year.
- Exchange Rate Effect was -$138000.0 for Q1 2026 at Ionis Pharmaceuticals, down from -$43000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $595000.0 in Q2 2025 to a low of -$486000.0 in Q4 2024.
- Historically, Exchange Rate Effect has averaged $13235.3 across 5 years, with a median of -$43000.0 in 2025.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect slumped 1800.0% in 2022, then jumped 2686.96% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $546000.0 in 2022, then tumbled by 39.56% to $330000.0 in 2023, then slumped by 247.27% to -$486000.0 in 2024, then soared by 91.15% to -$43000.0 in 2025, then sank by 220.93% to -$138000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$138000.0 (Q1 2026), -$43000.0 (Q4 2025), and -$82000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Dec 31, 2025 | -43,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Sep 30, 2025 | -82,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 595,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Mar 31, 2025 | 232,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Dec 31, 2024 | -486,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Sep 30, 2024 | 350,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Jun 30, 2024 | -23,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Mar 31, 2024 | -114,000.00 |
| Dec 31, 2023 | 330,000.00 |
| Dec 31, 2023 | 330,000.00 |